Evidence map›Paper›PMID 34904044›Full record

ArticleWorld journal of hepatology2021

Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan.

Guan-Woei Tseng, Mei-Chen Lin, Shih-Wei Lai, Cheng-Yuan Peng, Po-Heng Chuang, Wen-Pang Su, Jung-Ta Kao, Hsueh-Chou Lai

Open access · diamondAbstract read
In one paragraph

Article in World journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Postpartum related intrahepatic cholangiocarcinoma withJournal of gastrointestinal oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Guan-Woei TsengDepartment of Medicine, China Medical University, Taichung 40402, Taiwan.
Mei-Chen LinManagement Office for Health Data, China Medical University Hospital, Taichung 404, Taiwan.
Shih-Wei LaiDepartment of Family Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Cheng-Yuan PengCenter for Digestive Disease Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Po-Heng ChuangCenter for Digestive Disease Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Wen-Pang SuCenter for Digestive Disease Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Jung-Ta KaoCenter for Digestive Disease Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Hsueh-Chou LaiCenter for Digestive Disease Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
China Medical University · TWChina Medical University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile primary liver cancer (PLC) is one of the most common cancers around the world, few large-scale population-based studies have been reported that evaluated the clinical survival outcomes among peripartum and postmenopausal women with PLC.

aimTo investigate whether peripartum and postmenopausal women with PLC have lower overall survival rates compared with women who were not peripartum and postmenopausal.

methodsThe Taiwan National Health Insurance claims data from 2000 to 2012 was used for this propensity-score-matched study. A cohort of 40 peripartum women with PLC and a reference cohort of 160 women without peripartum were enrolled. In the women with PLC with/without menopause study, a study cohort of 10752 menopausal females with PLC and a comparison cohort of 2688 women without menopause were enrolled.

resultsPatients with peripartum PLC had a non-significant risk of death compared with the non-peripartum cohort [adjusted hazard ratios (aHR) = 1.40, 95% confidence intervals (CI): 0.89-2.20,

conclusionPeripartum females with PLC have no difference in survival rates compared with those patients without peripartum. Menopausal females with PLC have worse survival rates compared with those patients without menopause.

Indexed as

Nationwide cohortPeripartum and postmenopausal womenPeripartum womenPostmenopausal womenPrimary liver cancerPrognosis

Identifiers

PMID34904044
PMCPMC8637664
OpenAlexW3215211784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.